Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1

Status

Completed 5

Sponsor Class

OTHER 15NIH 8NETWORK 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5CNS 5

Conditions

Central Nervous System Neoplasms 7Lymphoma 6Glioblastoma 6Gliosarcoma 5Hodgkin Disease 4Astrocytoma 4Burkitt Lymphoma 3Recurrence 2Lymphoma, Non-Hodgkin 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Glioma 2Waldenstrom Macroglobulinemia 1Plasmablastic Lymphoma 1Neutropenia 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1HIV Infections 1Dendritic Cell Sarcoma, Interdigitating 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Radiotherapy 13Temozolomide 12Carmustine 5Chemotherapy, Adjuvant 3Radiosurgery 2Radiation 2Immunohistochemistry 2Everolimus 2Bevacizumab 2veliparib 1vatalanib 1sagopilone 1rubitecan 1mercaptoundecahydrododecaborate 1lonafarnib 1imetelstat 1beta-D-glucosylisophosphoramide mustard 1azurin (50-77) 1Tamoxifen 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Proton Therapy 1Perfusion Magnetic Resonance Imaging 1O(6)-benzylguanine 1Microarray Analysis 1Methotrexate 1Lomustine 1Leucovorin 1Irinotecan 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NETWORK × Gliosarcoma × Carmustine × Clear all
NCT00006386 2020-10-22

Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme

Radiation Therapy Oncology Group

Phase 2 Completed
80 enrolled
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00086879 2017-07-27

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
110 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00003417 2015-11-17

Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme

Radiation Therapy Oncology Group

Phase 1/2 Completed
40 enrolled
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00002545 2013-08-13

Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme

Radiation Therapy Oncology Group

Phase 3 Completed
200 enrolled
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00017147 2013-01-30

S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma

SWOG Cancer Research Network

Phase 3 Completed
183 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡